You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

Sienna Biopharmaceuticals losses higher than analysts expected

By   /   Thursday, August 9th, 2018  /   Comments Off on Sienna Biopharmaceuticals losses higher than analysts expected

    Print       Email
Research and development expenses more than doubled at Westlake Village-based Sienna Biopharmaceuticals during a “busy” second quarter, the company reported Aug. 9. Net losses were $1 per share, down from $6.50 per share for the previous second quarter, but still higher than analyst estimates of around 62 cents. Shares had fallen more than 3 percent…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Most tri-county stocks up as national indices dip

Read More →